CYP2A6 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein
Explore CYP2A6 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Secreted Protein/Potential Cytokines.
This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008]
| Target ID | GM-T06455 |
| Target Name | CYP2A6 |
|
Gene Group ldentifer (Target Gene ID in Homo species) |
1548 |
| Target Alternative Names | 1,4-cineole 2-exo-monooxygenase,CPA6,CYP2A,CYP2A3,CYP2A6,CYPIIA6,Coumarin 7-hydroxylase,Cytochrome P450 2A6,Cytochrome P450 IIA3,Cytochrome P450(I),P450C2A,P450PB |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Metabolic pathways, Chemical carcinogenesis - DNA adducts, Lipid and atherosclerosis, Retinol metabolism, Drug metabolism - cytochrome P450 |
| Target Classification | Tumor-associated antigen (TAA) |